Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TJY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,023
Award facts
- Contract value 100% obligated
- $14,023.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,023.19 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 13, 2026. The order was placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The place of performance is the company's facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery of BIKTARVY, a brand-name antiviral medication used in HIV treatment regimens, demonstrates the company's role in supplying specialized pharmaceutical products essential to military and federal healthcare operations. AmerisourceBergen's federal contracting portfolio reflects its capability to efficiently fulfill government requirements for both routine and specialized medications across multiple therapeutic domains through competitive, firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26F3TJY?
SPE2DR26F3TJY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F3TJY worth?
The government has obligated $14,023 on SPE2DR26F3TJY.
Is contract SPE2DR26F3TJY an order under another contract?
Yes. SPE2DR26F3TJY is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TJY competed?
The extent of competition for SPE2DR26F3TJY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award